A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV

Clinical trial NCT01448486 · TERMINATED

Trial details

NCT number: NCT01448486
Sponsor: St Vincent's Hospital, Sydney
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)HIV Associated Neurocognitive Disorders (HAND)

Start date: 2011-10-01
Primary completion: 2013-10-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.